Analyst firms · BofA Securities · BDX
BofA Securities BDX price target and rating history
Becton Dickinson and Company (BDX) · Health Care
BofA Securities rates Becton Dickinson and Company (BDX) Neutral with a $190 price target, as of its latest action on May 1, 2025. It has published 3 rating actions on BDX since March 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a BDX price target in the last 12 months, the median target is $191.
- Current rating
- Neutral
- Price target
- $190
- Median target, all firms
- $191
- Actions on BDX
- 3
BofA Securities price target on BDX
Every BofA Securities rating on BDX
- May 1, 2025
- Jan 3, 2023
- Mar 2, 2022
How other firms rate BDX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $242 | Nov 6, 2026 |
| Wolfe Research | Outperform | Oct 20, 2026 | |
| UBS | Buy | $19 | Jul 28, 2026 |
| Evercore ISI | Outperform | $180 | May 4, 2026 |
| Goldman Sachs | Neutral | $167 | Apr 10, 2026 |
| Barclays | Overweight | $202 | Feb 10, 2026 |
| Citigroup | Buy | $233 | Feb 3, 2026 |
Questions about BofA Securities and BDX
- What is BofA Securities's price target for BDX?
- BofA Securities's latest stated price target for Becton Dickinson and Company (BDX) is $190, from its action on May 1, 2025.
- What is BofA Securities's rating on BDX?
- BofA Securities rates BDX Neutral, a neutral rating, as of May 1, 2025.
- When did BofA Securities last change its view on BDX?
- On May 1, 2025, BofA Securities downgrades to Neutral from Buy, price target $190.
- How does BofA Securities's BDX target compare with other analysts?
- Across 6 firms with a BDX price target in the last 12 months, the median target is $191.
More BDX rating histories
All BofA Securities ratingsBDX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.